"Smartphones do their best to block scam links, so attackers use tricks to make their links clickable," said Joshua McKenty, CEO of Polyguard.ai, a cybersecurity company that helps businesses protect ...

And when facing the dilemma of production loss due to labor challenges, pre-engineered cobot solutions offer a practical ...

A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found. A colorized three dimensional micrographic scan of a melanoma cell. Recent ...

The Detroit Lions have had puzzling struggles on third-down early in the 2025 season, which has inhibited the success of an otherwise explosive offense. Through the first seven games of the 2025 ...

In many cells of the human body, hair-like protrusions known as cilia act as antennae, allowing cells to receive signals from their environment and other cells. As cells grow and divide, each cilium ...

The federal government shutdown continues without an end in sight. In just a few days, tens of millions of people are at risk of losing federal food and nutrition benefits as a result. This includes ...

Down syndrome affects around one in 640 children born in the US every year, and is the most common genetic cause of intellectual disability. About 15% of Downs cases are due to the presence of an ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Shares in Galapagos NV dropped sharply after the Belgian biotech firm said it would wind down its cell-therapy operations, putting paid to plans to sell the business off after no viable offers were ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

AMSTERDAM, Oct 21 (Reuters) - Biotechnology firm Galapagos (GLPG.AS), opens new tab said on Tuesday it would wind down its cell therapy business after attempts to sell it were unsuccessful, affecting ...